Locations - AstraZeneca
Our global locations. As a global organisation, we work together to bring life-changing medicines to millions of patients. Discover the impact you could have in our world-leading business.
AstraZeneca expands US manufacturing footprint to accelerate …
2024年2月6日 · AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply.
AstraZeneca plans $1.5 billion manufacturing facility for antibody …
2024年5月20日 · AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
2024年5月20日 · AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish ...
AstraZeneca to build US$1.5 billion cancer drug manufacturing plant …
2024年5月20日 · AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs) and targeted cancer therapies, the British company said on Monday (May...
Pharma giant AstraZeneca to build $2 billion manufacturing …
2024年5月21日 · SINGAPORE – Global biopharmaceutical company AstraZeneca intends to build a US$1.5 billion (S$2 billion) manufacturing facility in Singapore, the company said on May 20. It aims to begin the...
AstraZeneca in United States
AstraZeneca has several key R&D, manufacturing and commercial locations across the United States, including in Boston, MA, where the Gatehouse Park BioHub is thriving with several research companies and top scientists and experts.
AstraZeneca’s Cell Therapy Manufacturing Facility, Maryland, USA
2024年2月27日 · AstraZeneca, a biopharmaceutical company based in the UK, will build an advanced manufacturing facility in Rockville, Maryland, US, to launch its life-saving cell therapy platforms in the US, which are essential for critical cancer trials and future commercial supply.
AstraZeneca to invest $300M in US cell therapy plant
2024年2月7日 · AstraZeneca, looking to build its presence in cell therapy, plans to invest $300 million in a new manufacturing facility in Rockville, Maryland, that will focus on cancer treatments. The facility will manufacture cell therapies for the company’s clinical trials as well as future commercial supply, the U.K. drugmaker said Tuesday .
AstraZeneca to invest $360m in advanced manufacturing facility in Ireland
2021年9月21日 · AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to ensure the Company’s global supply network is fit for future growth.
跳至内容